In conclusion, our tumour-based discovery and validations, alongside in vitro and in vivo models, have identified a key role for viral/dsRNA response and IFN signalling, upstream of a STAT1-mediated cascade, which in turn drives an innate-adaptive immune activation, as a critical mediator of relapse in stroma-rich CRC. This evidence concerns the gene IFNA1 and colorectal carcinoma.